Supernus Pharmaceuticals (SUPN) Insider Trading & Ownership $36.22 +0.40 (+1.12%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Supernus Pharmaceuticals (NASDAQ:SUPN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$7.11 M Get SUPN Insider Trade Alerts Want to know when executives and insiders are buying or selling Supernus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SUPN Insider Buying and Selling by Quarter Ad Insiders Exposed917 Trades… Zero Losses?As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today Supernus Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/7/2024Frank MottolaSVPSell15,000$36.98$554,700.00 11/7/2024Georges GemayelDirectorSell14,213$36.62$520,480.06 11/7/2024Jack A KhattarCEOSell125,000$36.68$4,585,000.00 3/21/2024Padmanabh P BhattVPSell14,491$35.31$511,677.21 3/19/2024Padmanabh P BhattVPSell12,364$35.31$436,572.84 3/12/2024Padmanabh P BhattVPSell3,884$32.99$128,133.16 2/26/2024Padmanabh P BhattVPSell5,000$30.21$151,050.00 1/10/2024Tami Tillotson MartinVPSell8,000$27.91$223,280.00 (Data available from 1/1/2013 forward) SUPN Insider Trading Activity - Frequently Asked Questions Who is on Supernus Pharmaceuticals's Insider Roster? The list of insiders at Supernus Pharmaceuticals includes Frank Mottola, Frederick M Hudson, Georges Gemayel, Jack A Khattar, Padmanabh P Bhatt, and Tami Tillotson Martin. Learn more on insiders at SUPN. What percentage of Supernus Pharmaceuticals stock is owned by insiders? 9.30% of Supernus Pharmaceuticals stock is owned by insiders. Learn more on SUPN's insider holdings. Which Supernus Pharmaceuticals insiders have been selling company stock? The following insiders have sold SUPN shares in the last 24 months: Frank Mottola ($757,956.50), Frederick M Hudson ($259,150.50), Georges Gemayel ($520,480.06), Jack A Khattar ($7,117,574.55), Padmanabh P Bhatt ($1,614,429.73), and Tami Tillotson Martin ($644,694.65). How much insider selling is happening at Supernus Pharmaceuticals? Insiders have sold a total of 300,872 Supernus Pharmaceuticals shares in the last 24 months for a total of $10,914,285.99 sold. Supernus Pharmaceuticals Key ExecutivesMr. Jack A. Khattar (Age 63)Founder, President, CEO, Secretary & Director Compensation: $1.63M1 recent tradesMr. Timothy C. Dec (Age 65)Senior VP & CFO Compensation: $635.43kDr. Padmanabh P. Bhatt Ph.D. (Age 67)Chief Scientific Officer & Senior VP of Intellectual Property Compensation: $594.14kMr. Frank Mottola (Age 52)Senior Vice President of Quality, GMP Operations & Information Technology Compensation: $490.87k1 recent tradesDr. Jonathan Rubin M.D. (Age 63)MBA, Senior VP of Research & Development and Chief Medical Officer Compensation: $594.65kMr. Kevin T. Anderson (Age 62)Compliance Officer Dr. Todd Horich M.B.A.Ph.D., Senior Vice President of Marketing & Market AccessMr. Taylor RaifordSenior Vice President of SalesDr. Bryan A. Roecklein Ph.D.Senior Vice President of Corporate DevelopmentMs. Tami T. Martin Esq. (Age 69)R.N., Senior Vice President of Regulatory Affairs Compensation: $508.5k More Insider Trading Tools from MarketBeat Related Companies KNSA Insider Selling OCUL Insider Selling ARQT Insider Selling INVA Insider Selling PHAT Insider Selling ORIC Insider Selling KPTI Insider Selling BTAI Insider Selling JAZZ Insider Selling CORT Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:SUPN) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Supernus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Supernus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
